FimH-Mediated Host Interaction of Enterobacter cloacae in a Bladder Epithelial Cell Model
JoVE Encyclopedia of Experiments
Microbiology
0 views • 1:20 min • February 26th, 2026
Loading...
Overview
This study investigates the role of the FimH subunit in the adhesion of Enterobacter cloacae to human urinary bladder epithelial cells. The findings demonstrate that FimH is essential for bacterial adherence, as a mutant strain lacking FimH fails to attach to host cells.
Key Study Components
Area of Science
- Microbiology
- Cell Biology
- Pathogen-Host Interactions
Background
- Enterobacter cloacae is a pathogenic bacterium associated with urinary tract infections.
- Fimbriae, particularly the FimH subunit, play a critical role in bacterial adhesion to host cells.
- Understanding bacterial adhesion mechanisms can inform treatment strategies for infections.
- This study uses human urinary bladder epithelial cell cultures to explore these interactions.
Purpose of Study
- To determine the importance of FimH in the adhesion of Enterobacter cloacae to host cells.
- To compare the adhesion capabilities of wild-type and mutant strains of the bacterium.
- To provide insights into the mechanisms of bacterial pathogenesis.
Methods Used
- Culture of human urinary bladder epithelial cells in a multiwell plate.
- Incubation with wild-type and mutant strains of Enterobacter cloacae.
- Washing to remove unbound bacteria and lysis of host cells to release adhered bacteria.
- Serial dilution and plating on nutrient media to assess bacterial adhesion.
Main Results
- The control culture with wild-type bacteria yielded colonies, indicating successful adhesion.
- The experimental culture with the mutant strain showed no colonies, confirming lack of adhesion.
- Results highlight the critical role of FimH in bacterial attachment to host cells.
- Findings contribute to understanding the mechanisms of urinary tract infections.
Conclusions
- FimH is essential for the adhesion of Enterobacter cloacae to human urinary bladder epithelial cells.
- Mutant strains lacking FimH cannot adhere, demonstrating its role in pathogenesis.
- These insights may inform future therapeutic approaches to prevent bacterial infections.
Frequently Asked Questions
What is the significance of FimH in bacterial infections?
FimH is crucial for the adhesion of certain bacteria to host cells, influencing infection outcomes.
How does the mutant strain differ from the wild-type?
The mutant strain lacks FimH, which impairs its ability to adhere to host cells.
What methods were used to assess bacterial adhesion?
The study used cell cultures, incubation with bacterial strains, and plating on nutrient media.
What are the implications of this research?
Understanding bacterial adhesion mechanisms can lead to better prevention and treatment strategies for infections.
Can FimH be targeted for therapeutic purposes?
Yes, targeting FimH may provide a strategy to prevent bacterial adhesion and subsequent infections.
What type of cells were used in this study?
Human urinary bladder epithelial cells were used to model the interactions with Enterobacter cloacae.
Executive Industry Relevance
Understanding bacterial adhesion mechanisms provides critical target validation for anti-infective strategies. Demonstrating FimH as an essential virulence factor supports mechanistic de-risking in early discovery. This host-pathogen interaction model enables predictive confidence for therapeutic intervention prioritization.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Scientific Value: Interrogates therapeutic hypothesis of FimH as a key adhesion target in urinary tract infections.
- Operational Value: Provides functional validation of target essentiality through genetic mutant comparison.
- Predictive Value: Supports portfolio triage by confirming FimH blockade would impair bacterial pathogenesis.
Screening & Assay Development
- Assay Readiness: Establishes a reproducible host-cell infection model for compound screening against FimH-mediated adhesion.
- Quantitative Output: Enables measurement of bacterial adherence via colony-forming unit recovery after lysis and plating.
- Scalability: Uses multiwell plate format compatible with medium-throughput screening cascades.
Translational & Preclinical Research
- Disease Relevance: Models a clinically relevant step in Enterobacter cloacae pathogenesis using human bladder epithelial cells.
- Translational Continuity: Bridges target validation to preclinical evaluation of anti-adhesion therapeutics.
- Risk-Adjusted Decisions: Informs go/no-go criteria based on target mechanism confirmation in a disease-relevant system.
Pipeline & Workflow Integration
Positions FimH validation within early discovery to inform lead identification and preclinical workflows for anti-infective development.
- Discovery Biology: Supports hypothesis testing of FimH function in host-pathogen interactions and pathway clarification of virulence mechanisms.
- Screening: Describes assay readiness through standardized adhesion readout in a controlled cellular model.
- Analytics: Highlights quantitative dependent variable measurement (CFU counts) enabling comparison of wild-type versus mutant strain adherence.
- Translational Research: Connects to preclinical continuity by using human-derived cells to model infection relevance.
- Enterprise Reuse: Frames the epithelial cell infection model as a reusable platform for screening anti-adhesion compounds.
Operational & Enterprise Impact
- Scientific Value: Predictive confidence in target validation, reduction of mechanistic ambiguity in adhesion pathways.
- Operational Value: Standardized, reproducible infection model with quantifiable output.
- Strategic Value: Better go/no-go decisions, capital efficiency, reduced late-stage biological risk in anti-infective programs.
- Portfolio Impact: Risk-adjusted prioritization based on target essentiality confirmed in disease-relevant system.
Implementation Considerations
- Requires expertise in cell culture and microbiological techniques.
- Dependent on multiwell plate infrastructure and sterile incubation capabilities.
- Needs standardization across teams for consistent infection and washing protocols.
- Adaptation considerations for other bacterial strains or host cell types.
- Practical limitation: model reflects early adhesion step, not full infection cascade or in vivo complexity.
Biopharma FAQs
Why does null hypothesis testing matter for FimH target validation?
Null hypothesis testing determines whether observed adhesion differences between wild-type and mutant strains are statistically significant, supporting confident target essentiality claims.
How does isolating the FimH variable fit the discovery pipeline?
By comparing isogenic strains differing only in FimH expression, the study isolates the variable’s effect, enabling clear mechanistic interpretation in early target validation.
What do quantitative dependent variable measurements enable in this assay?
Colony-forming unit counts provide a quantitative readout of adhered bacteria, allowing objective comparison of adhesion efficiency across experimental conditions.
Why do replication requirements matter for cross-functional collaboration?
Replication ensures assay reliability across laboratories and teams, which is essential for transferring target validation data into downstream screening and lead optimization efforts.
What statistical analysis capabilities are required before implementing this model?
Implementation requires capability to perform statistical comparison of CFU data between conditions, such as t-tests or ANOVA, to validate significant differences in adhesion outcomes.
11:39
Assessing Autophagic Flux by Measuring LC3, p62, and LAMP1 Co-localization Using Multispectral Imaging Flow Cytometry
Related Videos
0 Views
10:33
Isolation of Salmonella typhimurium-containing Phagosomes from Macrophages
Related Videos
0 Views
11:20
Alveolar Macrophage Phagocytosis and Bacteria Clearance in Mice
Related Videos
0 Views
02:56
Isolation of Mouse Bladder Epithelial Cells Containing Intracellular Bacterial Communities
Related Videos
0 Views
05:23
Preparation of Mouse Bladder Tissue for Visualization of Bacterial Infection
Related Videos
0 Views
02:06
Visualizing Intracellular Bacterial Communities in an Infected Mouse Bladder
Related Videos
0 Views
11:20
Quantitative Assessment of Human Neutrophil Migration Across a Cultured Bladder Epithelium
Related Videos
0 Views
08:40
Establishment and Characterization of UTI and CAUTI in a Mouse Model
Related Videos
0 Views
07:34
Isolation of Single Intracellular Bacterial Communities Generated from a Murine Model of Urinary Tract Infection for Downstream Single-cell Analysis
Related Videos
0 Views
09:50
Detection of Tissue-resident Bacteria in Bladder Biopsies by 16S rRNA Fluorescence In Situ Hybridization
Related Videos
0 Views
Last updated: 18 July 2026